Macrogenics, Inc.
Overview
MacroGenics, Inc. is a biotechnology company focused on discovering and developing innovative monoclonal antibody-based therapies for the treatment of cancer. The company utilizes its proprietary antibody-based technologies to advance a diverse portfolio of products, from early stage development to late stage clinical trials.
Therapeutic areas
FDA compliance signals
No FDA recalls, Warning Letters, or Form 483 observations are linked to Macrogenics, Inc. in our records. PharmaTek screens the full directory against live FDA enforcement data.
Is this Macrogenics, Inc.? Get in front of buyers actively sourcing.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.